Search

AstraZeneca PLC

Closed

SectorHealthcare

162.66 -1.09

Overview

Share price change

24h

Current

Min

162.04

Max

162.94

Key metrics

By Trading Economics

Income

-1.4B

2.5B

Sales

96M

15B

P/E

Sector Avg

24.882

57.366

EPS

2.63

Dividend yield

1.95

Profit margin

16.095

Employees

96,100

EBITDA

-510M

5.2B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+34.28% upside

Dividends

By Acuity

Dividend yield

Sector Avg

1.95%

2.16%

Next Earnings

30 Oct 2026

Next Dividend date

8 Sept 2026

Market Stats

By TradingEconomics

Market Cap

-3.4B

259B

Previous open

163.75

Previous close

162.66

News Sentiment

By Acuity

60%

40%

273 / 340 Healthcare

AstraZeneca PLC Chart

Past performance is not a reliable indicator of future results.

Related News

29 Aug 2026, 00:02 UTC

News
Correlated Moves

Delta Air Lines shares are higher in after-market trading following the court's approval of its joint venture with Grupo Aeroméxico and record Q2 revenue of $17.7 billion.

29 Aug 2026, 00:02 UTC

News

Pinterest Inc shares declined in after-market trading following CFO Julia Brau Donnelly's resignation, effective October 30. Vikram Naidu will serve as interim CFO.

29 Aug 2026, 00:02 UTC

News

Chevron is nearing multi-billion-dollar deals to expand operations in Venezuela, boosting shares in after-market trading amid rising global crude prices.

29 Aug 2026, 00:01 UTC

News

Johnson & Johnson shares higher in after-market trading following FDA approval of Stelara for pediatric ulcerative colitis treatment, expanding its market potential.

29 Aug 2026, 00:01 UTC

News

Planet Fitness shares are lower in after-market hours following a class action lawsuit alleging misleading statements about customer metrics and growth guidance.

29 Aug 2026, 00:01 UTC

News

Blue Owl Capital Inc. shares rose in after-market trading following its $2.4 billion debt deal for Iren Ltd. to acquire Nvidia Blackwell Ultra GPUs.

29 Aug 2026, 00:01 UTC

News

Vistra Corp reports gross revenue of $17.74 billion and net income of $944 million. Shares are higher in after-market hours, reflecting strong institutional confidence.

29 Aug 2026, 00:01 UTC

News

Group 1 Automotive shares declined in after-market hours following multiple broker downgrades and price target reductions, including Barclays lowering its target to $365.

28 Aug 2026, 23:56 UTC

News

nVent Electric PLC will acquire Maverick Power for $1.75 billion, with additional performance-based payments. Shares are higher during after-market hours following the announcement.

28 Aug 2026, 23:46 UTC

News

Diamondback Energy shares declined after-market, despite earlier gains, amid rising market expectations for a rate hike and increased Treasury yields.

28 Aug 2026, 23:46 UTC

News

Target Corp filed for a mixed securities shelf and registered 15.5 million shares under its employee incentive plan. Shares remained roughly flat in after-market hours.

28 Aug 2026, 23:41 UTC

News

Blue Owl Capital gained in after-market trading after leading a $2.4 billion financing deal for Iren Ltd. to purchase Nvidia Blackwell Ultra GPUs.

28 Aug 2026, 23:41 UTC

News

Group 1 Automotive Inc shares declined in after-market hours, pressured by ratings downgrades from Barclays PLC and Weiss Ratings amid rising Treasury yields.

28 Aug 2026, 23:21 UTC

News

Incyte Corp shares are lower in after-market trading, continuing a trend of four consecutive sessions finishing down amid rising Treasury yields and mixed ESMO data sentiment.

28 Aug 2026, 23:21 UTC

News

Intuit Inc. shares are trading lower in after-market hours following a class action lawsuit alleging misleading statements about its financial performance and competitive advantages.

28 Aug 2026, 23:06 UTC

News

Coherus Oncology's $50 million common share offering pressures shares lower in after-market trading, marking a pullback from recent highs.

28 Aug 2026, 23:06 UTC

News

BioNTech SE shares are higher in after-market trading, supported by a Strong Buy rating and a cash position of $19.28 billion for R&D efforts.

28 Aug 2026, 23:06 UTC

Macro Event
News

Bitcoin is trading lower as hawkish comments from Federal Reserve Chairman Kevin Warsh raise interest rate expectations and geopolitical tensions impact investor confidence.

28 Aug 2026, 23:06 UTC

Macro Event
News

Bitcoin is trading lower as hawkish comments from Federal Reserve Chairman Kevin Warsh raise interest rate hike expectations and geopolitical tensions impact market confidence.

28 Aug 2026, 23:06 UTC

News

Lowe's Companies declared a quarterly cash dividend of $1.25 per share, boosting shares in after-market trading following the announcement.

28 Aug 2026, 23:06 UTC

News

Visa Inc shares are higher in after-market trading following a partnership with Dunamu to develop stablecoin payments and cross-border remittance services.

28 Aug 2026, 23:06 UTC

News

Michael Burry has reduced his stake in PayPal as acquisition talks with Advent International and Stripe have ended. Shares are slightly higher in after-hours trading.

28 Aug 2026, 23:02 UTC

News

Halliburton Co is positioned for multi-billion-dollar deals in Venezuelan crude reserves, contributing to higher shares in after-market hours.

28 Aug 2026, 23:01 UTC

News

Pinterest Inc shares declined in after-market trading following the resignation announcement of CFO Julia Brau Donnelly, effective October 30, 2026. Trading remains weak overall.

28 Aug 2026, 23:01 UTC

News

Chemours Co faces an investigation by Pomerantz LLP over potential securities law violations. Shares are trading higher in after-market hours despite concerns over internal controls.

28 Aug 2026, 23:01 UTC

News

Alnylam Pharmaceuticals shares rose in after-market hours, despite concerns from a failed cardiomyopathy trial. The company's market capitalization stands at $31.57 billion.

28 Aug 2026, 23:01 UTC

News

Flowers Foods shares are lower in after-market trading following the filing of a mixed securities shelf, raising potential concerns about dilution and financial strategy.

28 Aug 2026, 23:01 UTC

Event
News

Eli Lilly's shares rise in after-market trading following FDA approval of Mounjaro for reducing cardiovascular risks in type 2 diabetes patients.

28 Aug 2026, 23:01 UTC

News

Chevron is nearing multi-billion-dollar deals to expand operations in Venezuela, targeting two heavy-oil fields. Shares are trading higher in after-market hours.

28 Aug 2026, 23:01 UTC

News

McKesson Corp disclosed a cybersecurity incident affecting its information systems, with shares trading lower in after-market hours amid broader market weakness.

Peer Comparison

Price change

AstraZeneca PLC Forecast

Price Target

By TipRanks

34.28% upside

12 Months Forecast

Average 218.468 USD  34.28%

High 273.66 USD

Low 155.796 USD

Based on 15 Wall Street analysts offering 12 month price targets forAstraZeneca PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

15 ratings

13

Buy

1

Hold

1

Sell

Sentiment

By Acuity

273 / 340 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
help-icon Live chat